MiNK Therapeutics, Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2022 | $-4.2M | $-4.2M | — | $785.5K |
| Jun 2022 | $-4.6M | $-4.6M | — | $800.8K |
| Sep 2022 | $-5.6M | $-5.6M | — | $772.9K |
| Dec 2022 | $-4.4M | $-4.4M | — | $667.6K |
| Mar 2023 | $-4.4M | $-4.4M | $13.5K | $921.1K |
| Jun 2023 | $-4.2M | $-4.2M | $37.0K | $898.3K |
| Sep 2023 | $-4.2M | $-4.2M | $23.0K | $939.3K |
| Dec 2023 | $-3.0M | $-3.0M | $0 | $1.1M |
| Mar 2024 | $-2.5M | $-2.5M | — | $592.0K |
| Jun 2024 | $-2.3M | $-2.3M | — | $436.9K |
| Sep 2024 | $-3.0M | $-3.0M | — | $391.3K |
| Dec 2024 | $-1.7M | $-1.7M | — | $390.0K |
| Mar 2025 | $-1.3M | $-1.3M | — | $591.1K |
| Jun 2025 | $-1.6M | $-1.6M | — | $896.6K |
| Sep 2025 | $-941.3K | $-941.3K | — | $620.6K |
| Dec 2025 | $-2.1M | $-2.1M | — | $565.8K |
| Mar 2026 | $-1.7M | $-1.7M | — | $630.4K |
| Jun 2026 | $-2.1M | $-2.1M | — | $422.2K |